Target intelligence / Profile preview

Canine distemper virus hemagglutinin and fusion glycoproteins (CDV H/F)

Target
CDV H/F
Molecular classification
Viral glycoprotein, Viral envelope protein, Membrane fusion protein, Other
01

Overview

The Canine distemper virus (CDV) hemagglutinin (H) and fusion (F) glycoproteins form a critical envelope complex that mediates viral entry into host cells. The H glycoprotein acts as the attachment protein, binding to host cell receptors such as signaling lymphocyte activation molecule (SLAM/CD150) on immune cells and nectin-4 on epithelial cells. This receptor engagement triggers conformational changes in the H protein that are transmitted to the trimeric F glycoprotein, initiating irreversible refolding of F to fuse the viral envelope with the host cell membrane. Together, these glycoproteins are the primary targets for neutralizing antibodies and are essential components of live attenuated vaccines used to prevent canine distemper. Additionally, they serve as key targets for the development of novel entry inhibitors, small-molecule fusion blockers (such as 3G, F2736-3056, and F2261-0043), and neutralizing nanobodies (such as Nb-6C6) designed to treat acute infections.

Other names
Canine distemper virus H and F proteinsCanine distemper virus hemagglutinin and fusion proteinsCDV hemagglutinin and fusion glycoproteinsCDV H and F glycoproteinsCanine distemper virus fusogenic membrane glycoprotein complexCDV FMG complex
02

Mechanism of action

Inhibition of viral entry and membrane fusion by blocking the interaction between hemagglutinin (H) and fusion (F) glycoproteins, stabilizing the prefusion state of the F protein, or preventing receptor binding.

03

Biological functions

Viral entryMembrane fusionCell-to-cell fusionSyncytium formationHost cell attachmentOther
04

Disease associations

InfectionOther
05

Safety considerations

Rapid viral mutation leading to drug resistance (escape mutants)Immunogenicity of therapeutic antibodies or nanobodies in canine hostsPotential for cross-species transmission or altered host tropism due to mutations in H/FSuboptimal vaccine efficacy in wild carnivores compared to domestic dogs
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

Viral loadNeutralizing antibody titerSLAM (CD150) expressionNectin-4 expression

Beyond the preview

Go deeper on Canine distemper virus hemagglutinin and fusion glycoproteins (CDV H/F).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Canine distemper virus hemagglutinin and fusion glycoproteins (CDV H/F).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call